JWH-018 and JWH-073: Δ 9-tetrahydrocannabinol-like discriminative stimulus effects in monkeys

Brett C Ginsburg, David R. Schulze, Lenka Hruba, Lance R. McMahon

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Products containing naphthalen-1-yl-(1-pentylindol-3-yl) methanone (JWH-018) and naphthalen-1-yl-(1-butylindol-3-yl) methanone (JWH-073) are emerging drugs of abuse. Here, the behavioral effects of JWH-018 and JWH-073 were examined in one behavioral assay selective for cannabinoid agonism, rhesus monkeys (n = 4) discriminating Δ 9-tetrahydrocannabinol (Δ 9-THC; 0.1 mg/kg i.v.), and another assay sensitive to cannabinoid withdrawal, i.e., monkeys (n = 3) discriminating the cannabinoid antagonist rimonabant (1 mg/kg i.v.) during chronic Δ 9-THC (1 mg/kg s.c. 12 h) treatment. Δ 9-THC, JWH-018, and JWH-073 increased drug-lever responding in monkeys discriminating Δ 9- THC; the ED 50 values were 0.044, 0.013, and 0.058 mg/kg, respectively and the duration of action was 4, 2, and 1 h, respectively. Rimonabant (0.32-3.2 mg/kg) produced surmountable antagonism of Δ 9-THC, JWH-018, and JWH-073. Schild analyses and single-dose apparent affinity estimates yielded apparent pA 2/pK B values of 6.65, 6.68, and 6.79 in the presence of Δ 9-THC, JWH-018, and JWH- 073, respectively. In Δ 9-THC-treated monkeys discriminating rimonabant, the training drug increased responding on the rimonabant lever; the ED 50 value of rimonabant was 0.20 mg/kg. Δ 9- THC (1-10 mg/kg), JWH-018 (0.32-3.2 mg/kg), and JWH-073 (3.2-32 mg/kg) dose-dependently attenuated the rimonabantdiscriminative stimulus (i.e., withdrawal). These results suggest that Δ 9-THC, JWH-018, and JWH-073 act through the same receptors to produce Δ 9-THC-like subjective effects and attenuate Δ 9-THC withdrawal. The relatively short duration of action of JWH- 018 and JWH-073 might lead to more frequent use, which could strengthen habitual use by increasing the frequency of stimulusoutcome pairings. This coupled with the possible greater efficacy of JWH-018 at cannabinoid 1 receptors could be associated with greater dependence liability than Δ 9-THC.

Original languageEnglish (US)
Pages (from-to)37-45
Number of pages9
JournalJournal of Pharmacology and Experimental Therapeutics
Volume340
Issue number1
DOIs
StatePublished - Jan 2012

Fingerprint

Dronabinol
rimonabant
Haplorhini
Cannabinoids
1-pentyl-3-(1-naphthoyl)indole
JWH-073
Cannabinoid Receptor Antagonists
Cannabinoid Receptors
Street Drugs
Macaca mulatta
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Pharmacology
  • Molecular Medicine

Cite this

JWH-018 and JWH-073 : Δ 9-tetrahydrocannabinol-like discriminative stimulus effects in monkeys. / Ginsburg, Brett C; Schulze, David R.; Hruba, Lenka; McMahon, Lance R.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 340, No. 1, 01.2012, p. 37-45.

Research output: Contribution to journalArticle

@article{3aca4b600b21493eb93b04ab1282b513,
title = "JWH-018 and JWH-073: Δ 9-tetrahydrocannabinol-like discriminative stimulus effects in monkeys",
abstract = "Products containing naphthalen-1-yl-(1-pentylindol-3-yl) methanone (JWH-018) and naphthalen-1-yl-(1-butylindol-3-yl) methanone (JWH-073) are emerging drugs of abuse. Here, the behavioral effects of JWH-018 and JWH-073 were examined in one behavioral assay selective for cannabinoid agonism, rhesus monkeys (n = 4) discriminating Δ 9-tetrahydrocannabinol (Δ 9-THC; 0.1 mg/kg i.v.), and another assay sensitive to cannabinoid withdrawal, i.e., monkeys (n = 3) discriminating the cannabinoid antagonist rimonabant (1 mg/kg i.v.) during chronic Δ 9-THC (1 mg/kg s.c. 12 h) treatment. Δ 9-THC, JWH-018, and JWH-073 increased drug-lever responding in monkeys discriminating Δ 9- THC; the ED 50 values were 0.044, 0.013, and 0.058 mg/kg, respectively and the duration of action was 4, 2, and 1 h, respectively. Rimonabant (0.32-3.2 mg/kg) produced surmountable antagonism of Δ 9-THC, JWH-018, and JWH-073. Schild analyses and single-dose apparent affinity estimates yielded apparent pA 2/pK B values of 6.65, 6.68, and 6.79 in the presence of Δ 9-THC, JWH-018, and JWH- 073, respectively. In Δ 9-THC-treated monkeys discriminating rimonabant, the training drug increased responding on the rimonabant lever; the ED 50 value of rimonabant was 0.20 mg/kg. Δ 9- THC (1-10 mg/kg), JWH-018 (0.32-3.2 mg/kg), and JWH-073 (3.2-32 mg/kg) dose-dependently attenuated the rimonabantdiscriminative stimulus (i.e., withdrawal). These results suggest that Δ 9-THC, JWH-018, and JWH-073 act through the same receptors to produce Δ 9-THC-like subjective effects and attenuate Δ 9-THC withdrawal. The relatively short duration of action of JWH- 018 and JWH-073 might lead to more frequent use, which could strengthen habitual use by increasing the frequency of stimulusoutcome pairings. This coupled with the possible greater efficacy of JWH-018 at cannabinoid 1 receptors could be associated with greater dependence liability than Δ 9-THC.",
author = "Ginsburg, {Brett C} and Schulze, {David R.} and Lenka Hruba and McMahon, {Lance R.}",
year = "2012",
month = "1",
doi = "10.1124/jpet.111.187757",
language = "English (US)",
volume = "340",
pages = "37--45",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "1",

}

TY - JOUR

T1 - JWH-018 and JWH-073

T2 - Δ 9-tetrahydrocannabinol-like discriminative stimulus effects in monkeys

AU - Ginsburg, Brett C

AU - Schulze, David R.

AU - Hruba, Lenka

AU - McMahon, Lance R.

PY - 2012/1

Y1 - 2012/1

N2 - Products containing naphthalen-1-yl-(1-pentylindol-3-yl) methanone (JWH-018) and naphthalen-1-yl-(1-butylindol-3-yl) methanone (JWH-073) are emerging drugs of abuse. Here, the behavioral effects of JWH-018 and JWH-073 were examined in one behavioral assay selective for cannabinoid agonism, rhesus monkeys (n = 4) discriminating Δ 9-tetrahydrocannabinol (Δ 9-THC; 0.1 mg/kg i.v.), and another assay sensitive to cannabinoid withdrawal, i.e., monkeys (n = 3) discriminating the cannabinoid antagonist rimonabant (1 mg/kg i.v.) during chronic Δ 9-THC (1 mg/kg s.c. 12 h) treatment. Δ 9-THC, JWH-018, and JWH-073 increased drug-lever responding in monkeys discriminating Δ 9- THC; the ED 50 values were 0.044, 0.013, and 0.058 mg/kg, respectively and the duration of action was 4, 2, and 1 h, respectively. Rimonabant (0.32-3.2 mg/kg) produced surmountable antagonism of Δ 9-THC, JWH-018, and JWH-073. Schild analyses and single-dose apparent affinity estimates yielded apparent pA 2/pK B values of 6.65, 6.68, and 6.79 in the presence of Δ 9-THC, JWH-018, and JWH- 073, respectively. In Δ 9-THC-treated monkeys discriminating rimonabant, the training drug increased responding on the rimonabant lever; the ED 50 value of rimonabant was 0.20 mg/kg. Δ 9- THC (1-10 mg/kg), JWH-018 (0.32-3.2 mg/kg), and JWH-073 (3.2-32 mg/kg) dose-dependently attenuated the rimonabantdiscriminative stimulus (i.e., withdrawal). These results suggest that Δ 9-THC, JWH-018, and JWH-073 act through the same receptors to produce Δ 9-THC-like subjective effects and attenuate Δ 9-THC withdrawal. The relatively short duration of action of JWH- 018 and JWH-073 might lead to more frequent use, which could strengthen habitual use by increasing the frequency of stimulusoutcome pairings. This coupled with the possible greater efficacy of JWH-018 at cannabinoid 1 receptors could be associated with greater dependence liability than Δ 9-THC.

AB - Products containing naphthalen-1-yl-(1-pentylindol-3-yl) methanone (JWH-018) and naphthalen-1-yl-(1-butylindol-3-yl) methanone (JWH-073) are emerging drugs of abuse. Here, the behavioral effects of JWH-018 and JWH-073 were examined in one behavioral assay selective for cannabinoid agonism, rhesus monkeys (n = 4) discriminating Δ 9-tetrahydrocannabinol (Δ 9-THC; 0.1 mg/kg i.v.), and another assay sensitive to cannabinoid withdrawal, i.e., monkeys (n = 3) discriminating the cannabinoid antagonist rimonabant (1 mg/kg i.v.) during chronic Δ 9-THC (1 mg/kg s.c. 12 h) treatment. Δ 9-THC, JWH-018, and JWH-073 increased drug-lever responding in monkeys discriminating Δ 9- THC; the ED 50 values were 0.044, 0.013, and 0.058 mg/kg, respectively and the duration of action was 4, 2, and 1 h, respectively. Rimonabant (0.32-3.2 mg/kg) produced surmountable antagonism of Δ 9-THC, JWH-018, and JWH-073. Schild analyses and single-dose apparent affinity estimates yielded apparent pA 2/pK B values of 6.65, 6.68, and 6.79 in the presence of Δ 9-THC, JWH-018, and JWH- 073, respectively. In Δ 9-THC-treated monkeys discriminating rimonabant, the training drug increased responding on the rimonabant lever; the ED 50 value of rimonabant was 0.20 mg/kg. Δ 9- THC (1-10 mg/kg), JWH-018 (0.32-3.2 mg/kg), and JWH-073 (3.2-32 mg/kg) dose-dependently attenuated the rimonabantdiscriminative stimulus (i.e., withdrawal). These results suggest that Δ 9-THC, JWH-018, and JWH-073 act through the same receptors to produce Δ 9-THC-like subjective effects and attenuate Δ 9-THC withdrawal. The relatively short duration of action of JWH- 018 and JWH-073 might lead to more frequent use, which could strengthen habitual use by increasing the frequency of stimulusoutcome pairings. This coupled with the possible greater efficacy of JWH-018 at cannabinoid 1 receptors could be associated with greater dependence liability than Δ 9-THC.

UR - http://www.scopus.com/inward/record.url?scp=84055219353&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84055219353&partnerID=8YFLogxK

U2 - 10.1124/jpet.111.187757

DO - 10.1124/jpet.111.187757

M3 - Article

C2 - 21965552

AN - SCOPUS:84055219353

VL - 340

SP - 37

EP - 45

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 1

ER -